Private Equity Dives Into Booming Business of Clinical Trials
After success in other areas of medicine, private equity firms are pouring billions into the business of clinical drug trials.
Rachana Pradhan
Delicate Covid Vaccines Slow Rollout — Leading to Shots Given Out of Turn or, Worse, Wasted
The vaccines have a short shelf life, which forces clinicians to anticipate the exact number of doses they’ll need each day. If they don’t get it right, doses may go to waste.
How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID
Conflicts of interest have marred the U.S. government's vaccine effort, with billions showered on vaccine manufacturers that have U.S. officials on their boards.
CDC Coronavirus Testing Decision Likely To Haunt Nation For Months To Come
As the novel coronavirus snaked its way across the globe, the Centers for Disease Control and Prevention in early February distributed 200 test kits it had produced to more than 100 public health labs run by states and counties nationwide.
Trump’s Latest Health Care Challenge: Gaining Voters’ Trust
Far more Americans disapprove of President Donald Trump’s handling of several high-profile health care issues than give him positive marks, underscoring the challenge the president faces in claiming health care as a political asset in his reelection bid.
